206 related articles for article (PubMed ID: 32598971)
1. Targeted delivery of mitomycin C-loaded and LDL-conjugated mesoporous silica nanoparticles for inhibiting the proliferation of pterygium subconjunctival fibroblasts.
Wu M; Wang S; Wang Y; Zhang F; Shao T
Exp Eye Res; 2020 Aug; 197():108124. PubMed ID: 32598971
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antimitotic and antiangiogenic effect of preoperative subconjunctival application of mitomycin C in primary pterygium: a randomized trial.
Dos Santos Martins TG; de Azevedo Costa ALF; Furuzawa KM; Chammas R; Alves MR
Int Ophthalmol; 2019 Nov; 39(11):2435-2440. PubMed ID: 30761459
[TBL] [Abstract][Full Text] [Related]
3. Subconjunctival mitomycin C before pterygium excision: an ultrastructural study.
Chang YS; Chen WC; Tseng SH; Sze CI; Wu CL
Cornea; 2008 May; 27(4):471-5. PubMed ID: 18434852
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone modifies mitomycin C-triggered interleukin-8 secretion in isolated human Tenon's capsule fibroblasts.
Ho WT; Chen TC; Chou SF; Chang SW
Exp Eye Res; 2014 Jul; 124():86-92. PubMed ID: 24858696
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic Effects of Sakuraso-Saponin in Primary Cultured Pterygium Fibroblasts in Comparison With Mitomycin C.
Lee H; Jeong H; Lee CM; Shin JA; Jang SW; Lee JH; Park SY; Kim JY; Tchah H
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4784-4791. PubMed ID: 31743935
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctival injection of low doses of mitomycin C: effects on fibroblast proliferation.
Pinilla I; Larrosa JM; Polo V; Honrubia FM
Ophthalmologica; 1998; 212(5):306-9. PubMed ID: 9693286
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of low-density lipoprotein receptors stimulated by vascular endothelial growth factor in fibroblasts from pterygium.
Wu M; Wang J; Zhang Q; Wang Y; Niu L; Shao T
Biomed Pharmacother; 2017 Sep; 93():609-615. PubMed ID: 28686975
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study in combining application of mitomycin and amnion transplantation together with pterygium resection].
Huang Y; Wang B; Ye Q
Yan Ke Xue Bao; 2005 Dec; 21(4):110-3, 123. PubMed ID: 17162862
[TBL] [Abstract][Full Text] [Related]
9. Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.
Igaz N; Bélteky P; Kovács D; Papp C; Rónavári A; Szabó D; Gácser A; Kónya Z; Kiricsi M
Int J Nanomedicine; 2022; 17():3079-3096. PubMed ID: 35859731
[TBL] [Abstract][Full Text] [Related]
10. Subconjunctival bevacizumab injection in the surgery of primary pterygium: comparison with intraoperative mitomycin-C.
Kocabora SM; Fazil K; Ozsutcu M; Doyduk-Kocabora A; Gulkilik G
Bull Soc Belge Ophtalmol; 2013; (322):7-12. PubMed ID: 24923076
[TBL] [Abstract][Full Text] [Related]
11. Target drug delivery system as a new scarring modulation after glaucoma filtration surgery.
Shao T; Li X; Ge J
Diagn Pathol; 2011 Jul; 6():64. PubMed ID: 21736763
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effect of Valsartan on Pterygium Fibroblasts.
Küçük E; Aydemir I; Zor KR; Özkan O
Cornea; 2020 Sep; 39(9):1139-1144. PubMed ID: 32558732
[TBL] [Abstract][Full Text] [Related]
13. Preoperative subpterygeal injection vs intraoperative mitomycin C for pterygium removal: comparison of results and complications.
Khakshoor H; Razavi ME; Daneshvar R; Shakeri MT; Ghate MF; Ghooshkhanehi H
Am J Ophthalmol; 2010 Aug; 150(2):193-8. PubMed ID: 20570240
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival Short-term Evolution after Pterygium Excision.
Julio G; Lluch S; Pujol P; Dolores Merindano M; Soledad Marqués-Calvo M
Optom Vis Sci; 2015 Jul; 92(7):790-5. PubMed ID: 26083463
[TBL] [Abstract][Full Text] [Related]
15. Effects of mitomycin C on corneal endothelial cell counts in pterygium surgery: role of application location.
Kheirkhah A; Izadi A; Kiarudi MY; Nazari R; Hashemian H; Behrouz MJ
Am J Ophthalmol; 2011 Mar; 151(3):488-93. PubMed ID: 21236405
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival Autograft Combined With Either Preoperative Mitomycin C Injection or Intraoperative Local Mitomycin C Over the Medial Rectus Muscle Tendon in Primary Pterygium Surgery.
Lotfy A; Gad AAM; Abdelrahman A; Samir A; Abdulhalim BH
Eye Contact Lens; 2018 Nov; 44 Suppl 2():S192-S195. PubMed ID: 29420324
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision.
Donnenfeld ED; Perry HD; Fromer S; Doshi S; Solomon R; Biser S
Ophthalmology; 2003 May; 110(5):1012-6. PubMed ID: 12750105
[TBL] [Abstract][Full Text] [Related]
18. Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery.
da Costa Paula C; Julio G; Campos P; Pujol P; Asaad M
Curr Eye Res; 2017 May; 42(5):696-700. PubMed ID: 27854142
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up.
Koranyi G; Artzén D; Seregard S; Kopp ED
Acta Ophthalmol; 2012 May; 90(3):266-70. PubMed ID: 20528781
[TBL] [Abstract][Full Text] [Related]
20. Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery.
Cheng HC; Tseng SH; Kao PL; Chen FK
Cornea; 2001 Jan; 20(1):24-9. PubMed ID: 11188998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
